arginine and Deep Vein Thrombosis

arginine has been researched along with Deep Vein Thrombosis in 63 studies

Research

Studies (63)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (7.94)	18.2507
2000's	28 (44.44)	29.6817
2010's	27 (42.86)	24.3611
2020's	3 (4.76)	2.80

Authors

Authors	Studies
Fu, G; Liu, Z; Wang, Y; Yin, L; Zhang, K	1
Senoh, M; Sunami, K; Yokota, Y; Yoshioka, T	1
Chen, G; Ding, W; Li, K; Ma, D; Nansubuga, F; Wei, J; Weng, D; Wu, P; Yang, J; Yu, R	1
Bersinger, S; Lagarde, K; Marlu, R; Payen, JF; Pernod, G	1
Guo, Y; Huang, Z; Jia, L; Xing, G; Yun, X; Zou, Z	1
Gamberini, L; Laici, C; Loforte, A; Ravaioli, M; Siniscalchi, A	1
Greinacher, A; Heid, J; Katus, HA; Müller, OJ	1
Gleichgerrcht, E; Lim, MY; Turan, TN	1
Cao, Z; Han, X; Huang, X; Lin, J; Pu, Z; Ren, K; Sun, W; Tian, L; Wang, Y; Xu, J; Zhang, S; Zhou, W	1
Amic, E; Amic, F; Bilic, Z; Boban Blagaic, A; Drmic, D; Horvat Pavlov, K; Klicek, R; Kokot, A; Krezic, I; Milkovic Perisa, M; Pajtak, A; Peklic, M; Rakic, M; Seiwerth, S; Sikiric, P; Tvrdeic, A; Vidovic, T; Zizek, H; Zovak, M	1
Arays, R; McCarthy, P; Shmookler, AD	1
Dai, G; Liu, Q; Sun, L; Wang, C	1
Pötzsch, B	1
Asada, Y; Harada, A; Hattori, K; Inoue, O; Iwakiri, T; Kitazawa, T; Matsuda, S; Matsumoto, T; Matsuura, Y; Okuyama, N; Shima, M; Sugita, C; Yamashita, A	1
Dee, B; Gulbis, A; Lombardi Thomas, L	1
Akar, I; Ince, I; Senol, S; Tekumit, H	1
Arachchillage, DR; Baglin, T; Besser, M; Maclean, R; van Veen, JJ	1
Croci, E; Dentali, F; Giorgi-Pierfranceschi, M; Mumoli, N; Scarpioni, R	1
Chen, D; Dai, B; Dai, J; Jiang, Q; Li, L; Li, Q; Song, X; Teng, H; Xu, Z; Yan, W; Yang, F; Yao, Y	1
Al-Mondhiry, HA; Ambrose, A; Botti, JJ; Vaida, SJ; Young, SK	1
Maldonado, A	1
Fries, D	2
Hanson, GW; Malias, MA; Mitchell, GA; Sparkman, GM; Stowe, CL; Terneus, WF; Wellborn-Kim, JJ	1
Carlson, KB; DeSancho, MT; Mallik, A	1
Oo, TH	1
FU, FY; LIN, ZQ; LIU, ZJ; PAN, CQ; ZHOU, ZX	1
Ebina, Y; Miyata, S; Morita, H; Sonoyama, A; Tanimura, K; Yamada, H	1
Knovich, MA; Lesser, GJ; Strowd, RE	1
Baskaran, S; Biswas, L; Biswas, R; Mohan, CG; Nair, S; Oommen, AT; Prakash, O; Sivasundar, S	1
Bay, C; Bentz, S; Memari, S; Nowroozi, S; Sharifi, M; Valeros, G	1
Ahmed, S; Karim, A; Mattana, J; Patel, D; Siddiqui, R	1
Kaplan, KL	1
Dager, WE; White, RH	1
Bush, RL; Chen, C; Conklin, BS; Johnson, CK; Lin, PH; Lumsden, AB; Pullium, JK	1
Bauersachs, R; Brehme, S; Caspary, L; Creutzig, A; Harenberg, J; Hoffmann, U; Landgraf, H; Schellong, S	1
Buczko, W; Cylwik, D; Kramkowski, K; Mogielnicki, A; Stokowski, J	1
Bhatt, DL; Gurm, HS	1
Bozic, M; Budihna, MV; Cerne, M; Drevensek, G; Peternel, L; Stalc, A; Stegnar, M; Urleb, U; Zega, A	1
Fanikos, JR; Kubiak, DW; Szumita, PM	1
Hursting, MJ; Kelton, JG; Lewis, BE; Matthai, WH	1
Eto, T; Gondo, H; Hamasaki, N; Ichimiya, H; Kato, K; Kawamoto, M; Kayamori, Y; Muta, T; Okamura, T; Shibuya, T; Urata, M; Wada, Y; Yamanaka, M	1
Direskeneli, H; Saruhan-Direskeneli, G	1
Büller, HR; Di Nisio, M; Middeldorp, S	1
Hyers, TM	1
Dager, W; Spinler, SA	1
Chen, CY; Cooley, BC; Schmeling, G	1
Bucek, RA; Haider, DG; Hron, G; Kyrle, PA; Minar, E; Mittermayer, F; Reiter, M; Wolzt, M	1
de Mazancourt, P; de Raucourt, E; Fischer, AM; Meyer, G	1
Chen, C; El Sayed, HF; Kougias, P; Lin, PH; Okada, T; Rawat, A; Steinberg, JL; Yao, Q; Zhou, W	1
Kloecker, GH; Laber, DA; Martin, ME	1
Warkentin, TE	1
Berry, CN; Girardot, C; Lechaire, I; Lunven, C; O'Connor, SE	1
Carrasco, F; Gomez-Parra, M; Herrerias, JM; Jimenez-Saenz, M; Piñar, A; Rebollo, J; Saenz, R	1
Iwamoto, M; Morishita, K	1
Chi, HS; Kim, SB; Kim, SH; Kim, SW; Kim, TW; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Seo, EJ; Suh, C	1
Fukazawa, T; Goto, Y; Hayashi, H; Inoue, Y; Komatsu, Y	1
Berry, CN; Girard, D; Lecoffre, C; Lochot, S; Visconte, C	1
Cho, J; Dan, T; Kim, H; Koga, T; Koo, B; Seo, H; Yoshida, S; Yun, C	1
Cho, JH; Dan, T; Kim, HY; Koga, T; Koo, BA; Seo, HS; Yun, CH	1
Arnutti, P; Nathalang, O; Prayoonwiwat, W; Suwanasophon, C; Viputtigul, K	1

Reviews

10 review(s) available for arginine and Deep Vein Thrombosis

Article	Year
Argatroban: for a few selected patients. Prescrire international, 2013, Volume: 22, Issue:135 Topics: Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Interactions; Drug Substitution; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Patient Selection; Pipecolic Acids; Risk Assessment; Risk Factors; Sulfonamides; Thrombocytopenia; Treatment Outcome; Venous Thrombosis	2013
[Anticoagulation]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2013, Volume: 108, Issue:4 Topics: Administration, Oral; Anticoagulants; Antithrombins; Arginine; Arrhythmias, Cardiac; Blood Coagulation Tests; Factor Xa Inhibitors; Hemorrhage; Heparin; Heparinoids; Hirudins; Humans; Infusions, Intravenous; Orthopedic Procedures; Peptide Fragments; Pipecolic Acids; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Risk Factors; Secondary Prevention; Sulfonamides; Thromboembolism; Treatment Outcome; Venous Thrombosis; Vitamin K	2013
Successful use of argatroban during the third trimester of pregnancy: case report and review of the literature. Pharmacotherapy, 2008, Volume: 28, Issue:12 Topics: Adult; Anticoagulants; Arginine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gravidity; Humans; Infant, Newborn; Infusions, Intravenous; Pipecolic Acids; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Third; Purpura, Thrombocytopenic, Idiopathic; Sulfonamides; Treatment Outcome; Venous Thrombosis	2008
[Anticoagulation in critically ill patient]. Wiener medizinische Wochenschrift (1946), 2009, Volume: 159, Issue:19-20 Topics: Anticoagulants; Arginine; Biological Availability; Blood Coagulation Tests; Contraindications; Critical Care; Drug Monitoring; Heparin; Heparin, Low-Molecular-Weight; Humans; Pipecolic Acids; Pulmonary Embolism; Risk Factors; Sepsis; Shock, Septic; Sulfonamides; Venous Thrombosis	2009
Thrombosis prophylaxis in critically ill patients. Wiener medizinische Wochenschrift (1946), 2011, Volume: 161, Issue:3-4 Topics: Anticoagulants; Arginine; Biological Availability; Chromosome Breakage; Chromosome Disorders; Critical Care; Dose-Response Relationship, Drug; Drug Resistance; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Infusions, Intravenous; Injections, Subcutaneous; Pipecolic Acids; Recombinant Proteins; Risk Factors; Sepsis; Severity of Illness Index; Shock, Septic; Sulfonamides; Thrombin; Thrombocytopenia; Venous Thrombosis	2011
Direct thrombin inhibitors. Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:5 Topics: Antithrombins; Arginine; Coronary Disease; Half-Life; Hirudins; Humans; Metabolic Clearance Rate; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin; Venous Thrombosis	2003
[Prevention and treatment of deep vein thrombosis with ximelagatran]. Deutsche medizinische Wochenschrift (1946), 2004, Jul-23, Volume: 129, Issue:30 Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Fondaparinux; Glycine; Heparin; Hirudin Therapy; Humans; Pipecolic Acids; Polysaccharides; Prodrugs; Sulfonamides; Thrombin; Venous Thrombosis	2004
Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors. American heart journal, 2005, Volume: 149, Issue:1 Suppl Topics: Acute Disease; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Atrial Fibrillation; Azetidines; Benzylamines; Clinical Trials as Topic; Coronary Disease; Heparin; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thromboembolism; Thrombosis; Venous Thrombosis	2005
Heparin and other rapidly acting anticoagulants. Seminars in vascular surgery, 2005, Volume: 18, Issue:3 Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Embolism; Enzyme Inhibitors; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Venous Thrombosis	2005
Argatroban for anticoagulation during cardiac surgery. European journal of haematology, 2007, Volume: 78, Issue:2 Topics: Adult; Aged; Anticoagulants; Arginine; Cardiac Surgical Procedures; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Drug Monitoring; Endocarditis, Bacterial; Female; Heart Valve Prosthesis Implantation; Heparin; Humans; Intra-Aortic Balloon Pumping; Intraoperative Complications; Male; Middle Aged; Mitral Valve; Pipecolic Acids; Postoperative Complications; Retrospective Studies; Staphylococcal Infections; Subclavian Vein; Sulfonamides; Thrombosis; Venous Thrombosis; Warfarin; Whole Blood Coagulation Time	2007

Trials

3 trial(s) available for arginine and Deep Vein Thrombosis

Article	Year
Efficiency and safety evaluation of prophylaxes for venous thrombosis after gynecological surgery. Medicine, 2020, Jun-19, Volume: 99, Issue:25 Topics: Anticoagulants; Arginine; Endometrial Neoplasms; Female; Gynecologic Surgical Procedures; Heparin, Low-Molecular-Weight; Humans; Injections, Intravenous; Middle Aged; Ovarian Neoplasms; Pipecolic Acids; Postoperative Complications; Risk Factors; Sulfonamides; Uterine Cervical Neoplasms; Venous Thrombosis	2020
[Efficacy of regional administration of urokinase and argatroban via small saphenous vein catheter for treatment of acute deep venous thrombosis in the lower limb]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2011, Volume: 31, Issue:3 Topics: Adult; Arginine; Female; Fibrinolytic Agents; Humans; Injections, Intravenous; Lower Extremity; Male; Middle Aged; Pipecolic Acids; Saphenous Vein; Sulfonamides; Urokinase-Type Plasminogen Activator; Venous Thrombosis; Young Adult	2011
Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia. Thrombosis research, 2005, Volume: 116, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Arginine; Coronary Disease; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Venous Thrombosis	2005

Other Studies

50 other study(ies) available for arginine and Deep Vein Thrombosis

Article	Year
Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review. Annals of vascular surgery, 2022, Volume: 80 Topics: Aged; Anticoagulants; Antithrombins; Arginine; Dabigatran; Drug Therapy, Combination; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Sulfonamides; Thrombocytopenia; Venous Thrombosis	2022
Successful intravenous administration of argatroban in the management of heparin-resistant and surgery-resistant mesenteric vein thrombosis. BMJ case reports, 2019, Aug-15, Volume: 12, Issue:8 Topics: Administration, Intravenous; Aged; Antithrombins; Arginine; Female; Humans; Mesenteric Vascular Occlusion; Mesenteric Veins; Pipecolic Acids; Portal Vein; Splenic Vein; Sulfonamides; Treatment Outcome; Venous Thrombosis	2019
Using Nonheparin Anticoagulant to Treat a Near-Fatal Case With Multiple Venous Thrombotic Lesions During ChAdOx1 nCoV-19 Vaccination-Related Vaccine-Induced Immune Thrombotic Thrombocytopenia. Critical care medicine, 2021, 09-01, Volume: 49, Issue:9 Topics: Antithrombins; Arginine; Cerebral Veins; ChAdOx1 nCoV-19; COVID-19 Vaccines; Drug Therapy, Combination; Female; Fondaparinux; Humans; Immunoglobulins, Intravenous; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Tomography, X-Ray Computed; Venous Thrombosis; Young Adult	2021
Safety and effectiveness of argatroban versus heparin for preventing venous thromboembolism after lumbar decompressive surgery. International journal of surgery (London, England), 2017, Volume: 44 Topics: Adult; Aged; Anticoagulants; Arginine; Decompression, Surgical; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Incidence; Lumbar Vertebrae; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Postoperative Complications; Quality of Life; Retrospective Studies; Sulfonamides; Venous Thromboembolism; Venous Thrombosis	2017
Thrombolysis for acute pulmonary embolism after major hepatic surgery. Journal of clinical anesthesia, 2017, Volume: 42 Topics: Acute Disease; Adenocarcinoma; Appendiceal Neoplasms; Arginine; Atrial Fibrillation; Bronchoscopy; Catheters; Colectomy; Computed Tomography Angiography; Diagnosis, Differential; Electric Countershock; Fibrinolytic Agents; Heparin; Hepatectomy; Humans; Infusions, Intravenous; Intubation, Intratracheal; Liver Neoplasms; Lung; Male; Middle Aged; Pipecolic Acids; Postoperative Complications; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator; Troponin I; Ultrasonography; Venous Thrombosis	2017
Idiopathic catastrophic thrombosis with happy ending. BMJ case reports, 2017, Oct-23, Volume: 2017 Topics: Anticoagulants; Antithrombins; Arginine; Awareness; Blood Coagulation Tests; Coronary Artery Bypass; Heparin; Humans; Male; Middle Aged; Phenprocoumon; Pipecolic Acids; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome; Ultrasonography; Venous Thrombosis	2017
Cerebral Venous Sinus Thrombosis Due to Low-molecular-weight Heparin-induced Thrombocytopenia. The neurologist, 2017, Volume: 22, Issue:6 Topics: Anticoagulants; Arginine; Female; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Pipecolic Acids; Platelet Count; Sulfonamides; Thrombocytopenia; Thrombosis; Venous Thrombosis	2017
Thrombosis in the portal venous system caused by hypereosinophilic syndrome: A case report. Medicine, 2018, Volume: 97, Issue:48 Topics: Arginine; Critical Illness; Drug Therapy, Combination; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Heparin; Humans; Hypereosinophilic Syndrome; Male; Pipecolic Acids; Plasma Exchange; Platelet Aggregation Inhibitors; Portal System; Pulmonary Eosinophilia; Sulfonamides; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Urokinase-Type Plasminogen Activator; Venous Thrombosis; Young Adult	2018
Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine. World journal of gastroenterology, 2018, Dec-21, Volume: 24, Issue:47 Topics: Animals; Arginine; Colitis, Ischemic; Collateral Circulation; Disease Models, Animal; Duodenum; Humans; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Peptide Fragments; Protective Agents; Proteins; Random Allocation; Rats; Rats, Wistar; Treatment Outcome; Veins; Venous Thrombosis	2018
Inpatient management strategies in a severe case of heparin-induced thrombocytopenia. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2019, Volume: 58, Issue:4 Topics: Aged; Arginine; Coronary Artery Bypass; Female; Fondaparinux; Heparin; Humans; Pipecolic Acids; Platelet Count; Platelet Transfusion; Sulfonamides; Thrombocytopenia; Venous Thrombosis	2019
Application of thrombelastography in primary total knee and total hip replacement: a prospective 87 patients study. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2019, Volume: 30, Issue:6 Topics: Anticoagulants; Arginine; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Female; Humans; Male; Middle Aged; Partial Thromboplastin Time; Perioperative Care; Pipecolic Acids; Postoperative Care; Preoperative Care; Prospective Studies; Prothrombin Time; Pulmonary Embolism; Rivaroxaban; Sulfonamides; Thrombelastography; Thrombophilia; Venous Thrombosis	2019
Elevated plasma factor VIII enhances venous thrombus formation in rabbits: contribution of factor XI, von Willebrand factor and tissue factor. Thrombosis and haemostasis, 2013, Volume: 110, Issue:1 Topics: Animals; Antibodies, Blocking; Arginine; Blood Platelets; Factor VIII; Factor XI; Hemostasis; Humans; Jugular Veins; Male; Pipecolic Acids; Platelet Aggregation; Rabbits; Sulfonamides; Thrombin; Thromboplastin; Venous Thrombosis; von Willebrand Factor	2013
Heparin-induced thrombocytopenia. Prescrire international, 2013, Volume: 22, Issue:138 Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Sulfonamides; Thrombocytopenia; Venous Thrombosis	2013
Use of argatroban and catheter-directed thrombolysis with alteplase in an oncology patient with heparin-induced thrombocytopenia with thrombosis. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2014, May-01, Volume: 71, Issue:9 Topics: Antithrombins; Arginine; Autografts; Catheterization; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator; Venous Thrombosis	2014
The role of asymmetric and symmetric dimethylarginine in acute deep vein thrombosis. Annals of vascular surgery, 2015, Volume: 29, Issue:5 Topics: Acute Disease; Adult; Arginine; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Treatment Outcome; Venous Thrombosis	2015
Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant. Thrombosis research, 2016, Volume: 143 Topics: Adult; Aged; Anticoagulants; Antithrombins; Arginine; Dabigatran; Factor Xa Inhibitors; Female; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Neoplasms; Pipecolic Acids; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Sulfonamides; Venous Thrombosis	2016
Argatroban for Treatment of Heparin-Induced Thrombocytopenia and Thrombosis in a Patient with Multiple Myeloma Undergoing Hemodialysis. Journal of the American Geriatrics Society, 2016, Volume: 64, Issue:8 Topics: Aged, 80 and over; Anticoagulants; Antithrombins; Arginine; Dalteparin; Female; Humans; Multiple Myeloma; Partial Thromboplastin Time; Pipecolic Acids; Renal Dialysis; Sulfonamides; Thrombocytopenia; Venous Thrombosis	2016
Novel microspheres reduce the formation of deep venous thrombosis and repair the vascular wall in a rat model. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2017, Volume: 28, Issue:5 Topics: Animals; Arginine; Blood Coagulation; Disease Models, Animal; Drug Delivery Systems; P-Selectin; Rats; Rats, Sprague-Dawley; Venae Cavae; Venous Thrombosis	2017
Argatroban and catheter-directed thrombolysis with alteplase for limb- and graft-threatening thromboses in a patient with a history of HIT. American journal of hematology, 2009, Volume: 84, Issue:4 Topics: Aged; Antibodies, Anticardiolipin; Anticoagulants; Arginine; Catheterization; Contraindications; Drug Therapy, Combination; Femoral Vein; Heparin; Humans; Iliac Vein; Infusions, Intravenous; Ischemia; Kidney; Kidney Transplantation; Male; Pipecolic Acids; Popliteal Vein; Postoperative Complications; Protein S Deficiency; Purpura, Thrombocytopenic, Idiopathic; Renal Veins; Sulfonamides; Thrombolytic Therapy; Thrombophilia; Tissue Plasminogen Activator; Vena Cava Filters; Venous Thrombosis; Warfarin	2009
Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Jul-01, Volume: 67, Issue:13 Topics: Aged, 80 and over; Anticoagulants; Arginine; Coronary Artery Bypass; Female; Fondaparinux; Heparin; Humans; Mitral Valve; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Polysaccharides; Renal Dialysis; Sulfonamides; Thrombocytopenia; Venous Thrombosis	2010
A patient with 'spontaneous' heparin-induced thrombocytopenia and thrombosis after undergoing knee replacement. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:1 Topics: Anticoagulants; Antithrombins; Arginine; Arthroplasty, Replacement, Knee; Autoantibodies; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Factor 4; Sulfonamides; Thrombocytopenia; Venous Thrombosis	2011
Thrombolytic therapy and thrombectomy in phlegmasia cerulea dolens. The journal of the Royal College of Physicians of Edinburgh, 2010, Volume: 40, Issue:1 Topics: Anticoagulants; Antithrombins; Arginine; Fibrinolytic Agents; Heparin; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombectomy; Thrombocytopenia; Time Factors; Venous Thrombosis	2010
Argatroban therapy for heparin-induced thrombocytopenia during pregnancy in a woman with hereditary antithrombin deficiency. The journal of obstetrics and gynaecology research, 2012, Volume: 38, Issue:4 Topics: Adult; Anticoagulants; Antithrombins; Arginine; Blood Coagulation Disorders, Inherited; Female; Heparin; Humans; Male; Pipecolic Acids; Pregnancy; Pregnancy Complications, Hematologic; Sulfonamides; Thrombocytopenia; Venous Thrombosis	2012
The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies. Current treatment options in oncology, 2012, Volume: 13, Issue:4 Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Bevacizumab; Central Nervous System Neoplasms; Fondaparinux; Glioblastoma; Glioma; Hemorrhage; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vena Cava Filters; Venous Thromboembolism; Venous Thrombosis; Warfarin	2012
Molecular defect of 'Prothrombin Amrita': substitution of arginine by glutamine (Arg553 to Gln) near the Na(+) binding loop of prothrombin. Blood cells, molecules & diseases, 2013, Volume: 50, Issue:3 Topics: Amino Acid Substitution; Arginine; Glutamine; Heterozygote; Humans; Male; Middle Aged; Mutation; Protein Binding; Prothrombin; Sodium; Venous Thrombosis	2013
Catheter-directed thrombolysis with argatroban and tPA for massive iliac and femoropopliteal vein thrombosis. Cardiovascular and interventional radiology, 2013, Volume: 36, Issue:6 Topics: Arginine; Catheterization, Peripheral; Catheters; Drug Therapy, Combination; Female; Femoral Vein; Fibrinolytic Agents; Follow-Up Studies; Humans; Iliac Vein; Male; Middle Aged; Phlebography; Pipecolic Acids; Platelet Aggregation Inhibitors; Popliteal Vein; Recurrence; Severity of Illness Index; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis	2013
Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome. The American journal of the medical sciences, 2002, Volume: 324, Issue:5 Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Arginine; Arm; Enoxaparin; Female; Folic Acid; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Treatment Failure; Treatment Outcome; Venous Thrombosis; Warfarin	2002
Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD. The Annals of pharmacotherapy, 2003, Volume: 37, Issue:9 Topics: Acute Disease; Adult; Anticoagulants; Arginine; Fatal Outcome; Heparin; Humans; Infusions, Intravenous; Liver Failure; Male; Pipecolic Acids; Renal Dialysis; Renal Insufficiency; Sulfonamides; Thrombocytopenia; Venous Thrombosis	2003
L-arginine improves endothelial vasoreactivity and reduces thrombogenicity after thrombolysis in experimental deep venous thrombosis. Journal of vascular surgery, 2003, Volume: 38, Issue:6 Topics: Animals; Arginine; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Fibrinolytic Agents; Nitric Oxide; Swine; Thrombolytic Therapy; Tissue Plasminogen Activator; Venous Thrombosis	2003
Antithrombotic effect of L-arginine in hypertensive rats. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2004, Volume: 55, Issue:3 Topics: Animals; Arginine; Disease Models, Animal; Fibrinolysis; Fibrinolytic Agents; Hemostasis; Hypertension; Kidney; Male; Platelet Aggregation; Rats; Rats, Wistar; Venous Thrombosis	2004
Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models. Thrombosis and haemostasis, 2005, Volume: 93, Issue:3 Topics: Administration, Oral; Animals; Anticoagulants; Arginine; Blood Coagulation Tests; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fibrinolytic Agents; Injections, Subcutaneous; Male; Nadroparin; Phenylalanine; Pipecolic Acids; Rats; Rats, Wistar; Structure-Activity Relationship; Sulfonamides; Thrombin; Thrombophilia; Vena Cava, Inferior; Venous Thrombosis	2005
Extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:6 Topics: Aged; Anticoagulants; Arginine; Humans; Infusions, Intravenous; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Lung Neoplasms; Male; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Time Factors; Venous Thrombosis	2005
Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency. European journal of haematology, 2005, Volume: 75, Issue:2 Topics: Adult; Antithrombin III Deficiency; Arginine; DNA Mutational Analysis; Female; Frameshift Mutation; Heterozygote; Humans; Mesenteric Vascular Occlusion; Mesenteric Veins; Pipecolic Acids; Salvage Therapy; Sulfonamides; Treatment Outcome; Venous Thrombosis	2005
R92Q TNFRSF1A mutation and Behçet's disease: comment on the article by Amoura et al. Arthritis and rheumatism, 2005, Volume: 52, Issue:8 Topics: Arginine; Behcet Syndrome; Glutamine; Humans; Mutation; Receptors, Tumor Necrosis Factor, Type I; Venous Thrombosis	2005
Direct thrombin inhibitors. The New England journal of medicine, 2005, Sep-08, Volume: 353, Issue:10 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Arginine; Benzimidazoles; Blood Coagulation; Dabigatran; Heart Diseases; Heparin; Humans; Pipecolic Acids; Prodrugs; Pyridines; Sulfonamides; Thrombin; Thromboembolism; Thrombosis; Venous Thrombosis	2005
Comment: extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:11 Topics: Aged; Anticoagulants; Arginine; Humans; International Normalized Ratio; Kidney; Kidney Function Tests; Liver; Lung Neoplasms; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Venous Thrombosis; Warfarin	2005
Increased venous versus arterial thrombosis in the Factor V Leiden mouse. Thrombosis research, 2007, Volume: 119, Issue:6 Topics: Amino Acid Substitution; Animals; Arginine; Arterial Occlusive Diseases; Arteries; Chlorides; Disease Models, Animal; Factor V; Ferric Compounds; Gene Frequency; Glutamine; Homozygote; Mice; Mice, Inbred C57BL; Mutation; Thrombosis; Venous Thrombosis	2007
The cardiovascular risk marker asymmetrical dimethylarginine is not affected by venous thromboembolism. Translational research : the journal of laboratory and clinical medicine, 2006, Volume: 148, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aging; Arginine; Biomarkers; Body Mass Index; Female; Fibrin Fibrinogen Degradation Products; Humans; Male; Middle Aged; Risk Factors; Venous Thrombosis	2006
A Bbeta 14 Arg --> Cys fibrinogen variant in a patient with thrombotic complications (fibrinogen St-Germain III). Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:12 Topics: Adult; Arginine; Cysteine; Fibrinogen; Heterozygote; Humans; Male; Mutation; Pedigree; Pulmonary Embolism; Risk Factors; Thrombophilia; Venous Thrombosis	2006
Rheolytic pharmacomechanical thrombectomy in experimental chronic deep vein thrombosis: effect of L-arginine on thrombogenicity and endothelial vasomotor function. World journal of surgery, 2007, Volume: 31, Issue:4 Topics: Adenosine Diphosphate; Angiography; Animals; Arginine; Bradykinin; Calcimycin; Disease Models, Animal; Endosonography; Endothelium, Vascular; Microscopy, Electron, Scanning; Nitroprusside; Serotonin; Swine; Thrombectomy; Venous Thrombosis	2007
Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin. Thrombosis and haemostasis, 2008, Volume: 99, Issue:1 Topics: Acute Disease; Anticoagulants; Arginine; Blood Coagulation; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Heparin; Hirudins; Humans; International Normalized Ratio; Pipecolic Acids; Platelet Count; Polysaccharides; Recombinant Proteins; Research Design; Sulfonamides; Thrombin; Thrombocytopenia; Treatment Outcome; Venous Thrombosis; Warfarin	2008
Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosis. British journal of pharmacology, 1998, Volume: 125, Issue:1 Topics: Animals; Antibodies, Monoclonal; Anticoagulants; Arginine; Bleeding Time; Cross Reactions; Fibrinolytic Agents; Heparin; Humans; Male; Pipecolic Acids; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Rats; Sulfonamides; Thrombosis; Venous Thrombosis	1998
Portal and mesenteric vein thrombosis in a patient heterozygous for a mutation (Arg506-->Gln) in the factor V gen (factor V Leiden). Journal of clinical gastroenterology, 1998, Volume: 27, Issue:4 Topics: Adult; Arginine; Diagnosis, Differential; Factor V; Glutamine; Humans; Loss of Heterozygosity; Male; Mesenteric Veins; Portal Vein; Venous Thrombosis	1998
Synergistic antithrombotic effects of argatroban and ticlopidine in the rat venous thrombosis model. Thrombosis research, 1998, Dec-15, Volume: 92, Issue:6 Topics: Animals; Anticoagulants; Antithrombins; Arginine; Drug Synergism; Male; Pipecolic Acids; Rats; Rats, Wistar; Sulfonamides; Ticlopidine; Venous Thrombosis	1998
Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis. Journal of Korean medical science, 1998, Volume: 13, Issue:6 Topics: Activated Protein C Resistance; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Factor V; Glutamine; Humans; Korea; Middle Aged; Point Mutation; Prevalence; Venous Thrombosis	1998
Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban. Thrombosis and haemostasis, 1999, Volume: 81, Issue:2 Topics: Amino Acid Sequence; Animals; Arginine; Arterial Occlusive Diseases; Arteriovenous Shunt, Surgical; Chlorides; Drug Evaluation, Preclinical; Ferric Compounds; Fibrinolytic Agents; Glass; Hemorrhage; Heparin; Hirudin Therapy; Hirudins; Molecular Sequence Data; Pipecolic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Serine Proteinase Inhibitors; Sulfonamides; Thrombin; Thrombosis; Vena Cava, Inferior; Venous Thrombosis	1999
Activity of a sub-cutaneously administered novel mixed micellar formulation of argatroban in rat and rabbit models of venous thrombosis. Thrombosis and haemostasis, 2000, Volume: 84, Issue:2 Topics: Animals; Anticoagulants; Antithrombins; Arginine; Arteriovenous Shunt, Surgical; Bleeding Time; Blood Coagulation Tests; Carotid Arteries; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Compounding; Drug Evaluation, Preclinical; Hemostatics; Heparin; Injections, Subcutaneous; Male; Micelles; Pipecolic Acids; Rabbits; Rats; Sulfonamides; Thromboplastin; Venous Thrombosis	2000
In vitro and in vivo studies of AT-1362, a newly synthesized and orally active inhibitor of thrombin. Thrombosis research, 2000, Oct-01, Volume: 100, Issue:1 Topics: Administration, Oral; Amidines; Animals; Arginine; Binding, Competitive; Bleeding Time; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ferrous Compounds; Fibrinolytic Agents; Humans; Male; Molecular Structure; Partial Thromboplastin Time; Pipecolic Acids; Protein Binding; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Sulfonamides; Thrombin; Vascular Patency; Venous Thrombosis	2000
The antithrombotic efficacy of AT-1459, a novel, direct thrombin inhibitor, in rat models of venous and arterial thrombosis. Thrombosis and haemostasis, 2001, Volume: 86, Issue:6 Topics: Administration, Oral; Amidines; Animals; Arginine; Azepines; Bleeding Time; Carotid Artery Thrombosis; Dalteparin; Drug Evaluation, Preclinical; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Molecular Structure; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Sulfonamides; Thrombin; Vena Cava, Inferior; Venous Thrombosis; Warfarin	2001
Mutations at the activated protein C cleavage sites Arg336 and Arg562 of factor VIII in Thai patients with venous thrombosis. The Southeast Asian journal of tropical medicine and public health, 2001, Volume: 32, Issue:4 Topics: Adult; Aged; Amino Acid Substitution; Arginine; Base Sequence; Case-Control Studies; DNA Primers; Factor VIII; Female; Heterozygote; Homozygote; Humans; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Protein C; Thailand; Venous Thrombosis	2001